1-3 of 3
Brent L. Wood
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph + acute lymphoblastic leukemia

Clinical Trials & Observations
Anjali S. Advani, Anna Moseley, Kristen M. O’Dwyer, Brent L. Wood, Jae Park, Matthew Wieduwilt, Deepa Jeyakumar, George Yaghmour, Ehab L. Atallah, Aaron T. Gerds, Susan M. O'Brien, Jane L. Liesveld, Megan Othus, Mark Litzow, Richard M. Stone, Elad Sharon, Harry P. Erba
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1279–1285.
https://doi.org/10.1182/bloodadvances.2022008216
Published: 2023
Includes: Supplemental data
Journal Articles

CD22 low /Bcl-2 high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia

Clinical Trials & Observations
Astrid Wintering, Kenichi Ishiyama, Stanley Tamaki, Courtney Tamaki, Joshua Fandel, Lingyun Ji, Brent L. Wood, Nirali N. Shah, Constance M. Yuan, Maureen M. O’Brien, Mignon L. Loh, Ernesto Diaz-Flores
Journal: Blood Advances
Blood Adv (2023) 7 (2): 251–255.
https://doi.org/10.1182/bloodadvances.2021006810
Published: 2023
Includes: Supplemental data
Journal Articles

VpreB surrogate light chain expression in B-lineage ALL: a report from the Children’s Oncology Group

Stuart S. Winter, Amanda McCaustland, Chunxu Qu, No’eau Simeona, Nyla A. Heerema, Andrew J. Carroll, Brent L. Wood, Gabriela Gheorghe, Charles G. Mullighan, Bridget S. Wilson
Journal: Blood Advances
Blood Adv (2022) 6 (2): 585–589.
https://doi.org/10.1182/bloodadvances.2021005245
Published: 2022
Includes: Supplemental data